Skip to main content

. 1966 Feb 19;1(5485):461–463. doi: 10.1136/bmj.1.5485.461

Cutaneous Hepatic Porphyria and Oestrogens

P W Monckton Copeman, D J Cripps, R Summerly

PMCID: PMC1843617 PMID: 5902684

461

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BLEIBERG J., WALLEN M., BRODKIN R., APPLEBAUM I. L. INDUSTRIALLY ACQUIRED PORPHYRIA. Arch Dermatol. 1964 Jun;89:793–797. doi: 10.1001/archderm.1964.01590300021006. [DOI] [PubMed] [Google Scholar]
BRUNSTING L. A. Observations on porphyria cutanea tarda. AMA Arch Derm Syphilol. 1954 Nov;70(5):551–564. doi: 10.1001/archderm.1954.01540230001001. [DOI] [PubMed] [Google Scholar]
DE MATTEIS F., RIMINGTON C. The biochemical disturbance in acute intermittent and experimental porphyria. Lancet. 1962 Jun 23;1(7243):1332–1334. doi: 10.1016/s0140-6736(62)92427-3. [DOI] [PubMed] [Google Scholar]
EALES L., DOWDLE E. B., SAUNDERS S. J., SWEENEY G. D. THE DIAGNOSTIC IMPORTANCE OF FAECAL PORPHYRINS IN THE DIFFERENTIATION OF THE PORPHYRIAS. II. VALUES IN THE CUTANEOUS PORPHYRIAS. S Afr J Lab Clin Med. 1963 Sep;18:126–134. [PubMed] [Google Scholar]
MARSDEN C. W. Porphyria during chloroquine therapy. Br J Dermatol. 1959 Jun;71(6):219–222. doi: 10.1111/j.1365-2133.1959.tb13411.x. [DOI] [PubMed] [Google Scholar]
MAUZERALL D., GRANICK S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956 Mar;219(1):435–446. [PubMed] [Google Scholar]
RIMINGTON C., MORGAN P. N., NICHOLLS K., EVERALL J. D., DAVIES R. R. GRISEOFULVIN ADMINISTRATION AND PORPHYRIN METABOLISM. A SURVEY. Lancet. 1963 Aug 17;2(7303):318–322. doi: 10.1016/s0140-6736(63)92989-1. [DOI] [PubMed] [Google Scholar]
SCHMID R. Cutaneous porphyria in Turkey. N Engl J Med. 1960 Aug 25;263:397–398. doi: 10.1056/NEJM196008252630807. [DOI] [PubMed] [Google Scholar]
SWEENEY G. D., SAUNDERS S. J., DOWDLE E. B., EALES L. EFFECTS OF CHLOROQUINE ON PATIENTS WITH CUTANEOUS PORPHYRIA OF THE "SYMPTOMATIC" TYPE. Br Med J. 1965 May 15;1(5445):1281–1285. doi: 10.1136/bmj.1.5445.1281. [DOI] [PMC free article] [PubMed] [Google Scholar]
THEOLOGIDES A., KENNEDY B. J., WATSON C. J. A STUDY OF THE URINARY PORPHYRINS AND PORPHYRIN PRECURSORS IN PATIENTS WITH MALIGNANT DISEASE RECEIVING DIETHYLSTILBESTROL. Metabolism. 1964 May;13:391–395. doi: 10.1016/0026-0495(64)90112-x. [DOI] [PubMed] [Google Scholar]
WATSON C. J., RUNGE W., BOSSENMAIER I. Increased urinary porphobilinogen and uroporphyrin after administration of stilboestrol in a case of latent porphyria. Metabolism. 1962 Nov;11:1129–1133. [PubMed] [Google Scholar]
WATSON C. J. The problem of porphyria--some facts and questions. N Engl J Med. 1960 Dec 15;263:1205–1215. doi: 10.1056/NEJM196012152632401. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES